1 / 8

The Lilly MDR-TB Partnership

The Lilly MDR-TB Partnership. Increasing Corporate Engagement on Tuberculosis Metropolitan Auditorium, Cape Town, 23.02.2010. Creating a sustainable strategy for combating a global public health pandemic. 360° Approach: Partnership Overview. Since 2003, Lilly has lead a comprehensive approach

laird
Télécharger la présentation

The Lilly MDR-TB Partnership

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Lilly MDR-TB Partnership Increasing Corporate Engagement on Tuberculosis Metropolitan Auditorium, Cape Town, 23.02.2010 Creating a sustainable strategy for combating a global public health pandemic

  2. 360° Approach: Partnership Overview Since 2003, Lilly has lead a comprehensive approach to fighting MDR-TB through Awareness and Prevention Community Support and Patient Advocacy Treatment, Training and Surveillance Research Transferring Technology Reaching patients throughout the world

  3. International Organizations and NGOs International Federation of Red Cross & Red Crescent Societies World Health Organization Foundation for Professional Development Centers for Disease Control World Economic Forum Global Business Coalition UNICEF USAID Government Departments Department of Health Department of Public Service and Administration Healthcare Provider Networks International Hospital Federation International Council of Nurses - DENOSA World Medical Association - SAMA Manufacturing Partners Aspen Pharmacare (South Africa) Hisun (China) Shasun (India) SIA/Biocom (Russia) The Partners

  4. World Economic Forum/GBC Develop a Global Awareness Toolkit for Tuberculosis/MDR-TB in the workplace and disseminate through WEF/GBC member companies Provide educational material targeting employees and in-plant healthcare staff Pilot tested in India and adapt for other high-burden countries with large business communities Conducted 3 workshops in South Africa in 2009 reaching over 60 participants from 33 companies Workplace Toolkit

  5. Share Lilly’s specific and general manufacturing knowledge Create self-sustaining centers of manufacturing excellence capable of providing additional products and employment Support reliable generic producers to ensure expanded multi-source availability of the two drugs Offer manufacturing firms in MDR-TB “hot spots” the technology to produce capreomycin and cycloserine Give training in GMPs and Good Business Practices Provide 10 full-time Lilly staff on-site over 4 years for technical assistance/training Facilities in China and India receive technology to produce capreomycin and cycloserine API’s respectively, and South Africa and Russia produce both products Transferring of Technology

  6. Technology successfully transferred to “hot spot” producers

  7. THANK YOU!!!

  8. Thank You! Dr Osborn Mahanjana Corporate Affairs Director Lilly MDR-TB Partnership mahanjanaos@lilly.com South Africa www.lilly.com www.lillymdr-tb.com

More Related